BioLife Solutions, Inc. Additional Paid in Capital, Common Stock
BioLife Solutions, Inc. (BLFS) had Additional Paid in Capital, Common Stock of $713.57 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $713.57M.
- 2026-03-31: Additional Paid in Capital, Common Stock $710.81M.
- 2025-12-31: Additional Paid in Capital, Common Stock $711.40M.
- 2025-09-30: Additional Paid in Capital, Common Stock $704.33M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $713.57M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $710.81M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $711.40M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $704.33M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $698.42M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $688.09M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $683.94M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $673.18M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $667.81M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $659.06M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $652.88M 10-K · filed 2025-03-03 | $651.30M 10-K · filed 2024-02-29 |
| 2023-09-30 | $632.59M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $623.41M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $619.23M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $611.74M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $604.06M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $597.81M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $591.00M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $585.40M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $579.93M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $542.86M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $307.25M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $302.60M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $282.08M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $199.94M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $145.43M 10-Q · filed 2020-05-29 | |
| 2019-12-31 | $143.49M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $138.21M 10-K · filed 2020-05-15 | $137.39M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $115.36M 10-K · filed 2020-05-15 | $116.01M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $113.80M 10-K · filed 2020-05-15 | $114.95M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $113.01M 10-K · filed 2020-05-15 | $114.16M 10-K · filed 2019-03-15 |
| 2018-09-30 | $112.75M 10-K · filed 2020-05-15 | $115.78M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $81.76M 10-K · filed 2020-05-15 | $92.65M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $64.02M 10-K · filed 2020-05-15 | $84.52M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $84.04M 10-K · filed 2019-03-15 | $84.04M 10-K · filed 2018-03-09 |
| 2017-09-30 | $80.49M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $79.68M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $74.89M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $74.36M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $74.03M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $73.72M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $72.98M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $72.82M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $72.35M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $72.15M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $71.97M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $71.91M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $71.86M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $71.73M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $71.52M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $43.62M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $43.48M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $43.37M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $43.35M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $43.32M 10-K · filed 2014-02-12 | $43.26M 10-K · filed 2013-03-29 |
| 2012-09-30 | $43.19M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $43.14M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $42.95M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $42.90M 10-K · filed 2013-03-29 | |
| 2011-09-30 | $42.85M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $42.71M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $42.58M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |